Clinical trial

Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors

NCT00054977

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-02-01

PhasePHASE1

Study timeline

Study start (unknown)2003-02-01Date precision: month

Registry last updated2012-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Colorectal Cancerunresolved

Lung Cancerunresolved

Breast Cancerunresolved

Head and Neck Cancerunresolved

Prostate Cancerunresolved

Interventions

5-fluorouracilDRUG

Sponsors & collaborators

Galectin Therapeutics Inc.lead sponsor

Mapped research locations

JacksonvilleFlorida, United States1 Ann ArborMichigan, United States1 New OrleansLouisiana, United States1 LebanonNew Hampshire, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00054977 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.